Out-Of-State Claims Dropped In Calif. Heart Drug Suit

Law360 (July 31, 2020, 5:49 PM EDT) -- A California appeals court won't let out-of-state residents' claims against out-of-state pharmaceutical companies go forward in a suit over the marketing of the heart medication amiodarone, saying those companies' contracts with California-based McKesson Corp. don't give the court jurisdiction over them.

In an unpublished opinion Thursday, the state's court of appeals affirmed an Alameda County court ruling quashing service of claims against the non-California companies — which include a Pfizer unit, Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc. and Sandoz Inc. — by non-California residents, as they haven't shown that any of the companies have enough of a connection to the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!